Owlstone Medical wins $6.5m from Gates Foundation
Owlstone Medical, a global leader in Breath Biopsy® for applications in early disease detection and precision medicine, has secured $6.5 million funding from the Bill & Melinda Gates Foundation.
Stay updated with breaking news from Billy Boyle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Owlstone Medical, a global leader in Breath Biopsy® for applications in early disease detection and precision medicine, has secured $6.5 million funding from the Bill & Melinda Gates Foundation.
Funding represents the first time the foundation has taken an equity position in a breath diagnostics company.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Owlstone Medical's exegenous volatile organic compound (EVOC) breath test can reveal signs of liver cirrhosis and portal hypertension, a study has found.